title: Questions about the formulation of erythropoietin mouthwash for the prevention of oral mucositis.
authors.affiliation: Service of Pharmacy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.|School of Pharmaceutical Science (EPGL), Genève-Lausanne, Switzerland.
authors.forename: Mapi
authors.identifier: http://orcid.org/0000-0002-4462-9201
authors.initials: M
authors.lastname: Fleury
authors.affiliation: Department of Medical Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
authors.forename: Keyvan
authors.initials: K
authors.lastname: Shabafrouz
authors.affiliation: Department of Medical Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
authors.forename: Gael
authors.initials: G
authors.lastname: Deplanque
mesh_terms: D004921:Erythropoietin / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D009067:Mouthwashes / Q000737:chemistry / Q000494:pharmacology; D013280:Stomatitis / Q000517:prevention & control*
chemical_list: C554270:EPO protein, human; D009067:Mouthwashes; D004921:Erythropoietin
keywords: drug formulation; erythropoietin; oral mucositis